When Vertex Pharmaceuticals announced last month that its pain pill had received approval from the U.S. Food and Drug Administration (FDA), it marked a major breakthrough in the hunt for new ...

Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...

A research team has developed a non-opioid medication that shows promise in treating acute and chronic pain. The drug, known ...

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity ... Journavx was found to be similarly effective as hydrocodone, an opioid pain medication for reducing acute pain, ...

as the FDA has approved a first-of-its-kind pain medication, and it’s one without the addiction potential of opioids. The FDA has just approved Journavx (suzetrigine) for moderate to severe acute pain ...

Sen. Mark Kelly champions the PAIN Act to improve seniors' access to non-opioid pain treatments under Medicare.